Anti-platelet Therapy in the Primary Prevention of Cardiovascular Disease in Patients with Chronic Obstructive Pulmonary Disease
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 01 Jun 2017
At a glance
- Drugs Ticagrelor (Primary) ; Aspirin
- Indications Chronic obstructive pulmonary disease
- Focus Pharmacodynamics
- Acronyms APPLE-COPD:ICON 2
- 01 Jun 2017 Status changed from recruiting to active, no longer recruiting.
- 09 Dec 2015 Accrual to date is 2% according to United Kingdom Clinical Research Network record.
- 10 Nov 2015 Accrual to date is 0% according to United Kingdom Clinical Research Network record.